Regardless, the correlation between fluciclovine uptake and ASCT2 supports the notion that within these glioblastoma models, fluciclovine PET can provide reliable quantification of tumor metabolism (or more specifically, uptake of amino acids mediated by high-affinity glutamine transporter ASCT2). The gene discussed is SLC1A5; the disease is glioblastoma.